Caladrius Biosciences

-$0.0171 (-3.65%) Today
+$0.047 (+10.40%) As of 11:38 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLBS and other ETFs, options, and stocks.

About CLBS

Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14.

CEO
David J. Mazzo
Employees
27
Headquarters
Basking Ridge, New Jersey
Founded
1980

CLBS Key Statistics

Market cap
27.35M
Price-Earnings ratio
—
Dividend yield
—
Average volume
182.77K
High today
$0.4833
Low today
$0.452
Open price
$0.454
Volume
141.66K
52 Week high
$1.68
52 Week low
$0.4019

CLBS Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure